BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26403997)

  • 1. Plasma MMP and TIMP evaluation in patients with deep venous thrombosis: could they have a predictive role in the development of post-thrombotic syndrome?
    de Franciscis S; Gallelli L; Amato B; Butrico L; Rossi A; Buffone G; Caliò FG; De Caridi G; Grande R; Serra R
    Int Wound J; 2016 Dec; 13(6):1237-1245. PubMed ID: 26403997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers and the post-thrombotic syndrome: A systematic review of biomarkers associated with the occurrence of the post-thrombotic syndrome after lower extremity deep venous thrombosis.
    Harbsmeier AN; Altintas I; Iversen K; Andersen O; Nehlin JO
    Phlebology; 2023 Oct; 38(9):577-598. PubMed ID: 37620994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome.
    Bittar LF; Silva LQD; Orsi FLA; Zapponi KCS; Mazetto BM; Paula EV; Montalvão SAL; Annichino-Bizzacchi JM
    PLoS One; 2020; 15(1):e0227150. PubMed ID: 31945777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.
    Metz AK; Diaz JA; Obi AT; Wakefield TW; Myers DD; Henke PK
    Methodist Debakey Cardiovasc J; 2018; 14(3):173-181. PubMed ID: 30410646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome.
    Rabinovich A; Cohen JM; Cushman M; Wells PS; Rodger MA; Kovacs MJ; Anderson DR; Tagalakis V; Lazo-Langner A; Solymoss S; Miron MJ; Yeo E; Smith R; Schulman S; Kassis J; Kearon C; Chagnon I; Wong T; Demers C; Hanmiah R; Kaatz S; Selby R; Rathbun S; Desmarais S; Opatrny L; Ortel TL; Ginsberg JS; Kahn SR
    J Thromb Haemost; 2015 Mar; 13(3):398-408. PubMed ID: 25495610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis.
    Bittar LF; Mazetto Bde M; Orsi FL; Collela MP; De Paula EV; Annichino-Bizzacchi JM
    Thromb Res; 2015 Mar; 135(3):497-501. PubMed ID: 25575413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of natural history of deep vein thrombosis: early predictors of poor late outcomes.
    van Rij AM; Hill G; Krysa J; Dutton S; Dickson R; Christie R; Smillie J; Jiang P; Solomon C
    Ann Vasc Surg; 2013 Oct; 27(7):924-31. PubMed ID: 23816387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome.
    Bouman AC; Smits JJ; Ten Cate H; Ten Cate-Hoek AJ
    J Thromb Haemost; 2012 Aug; 10(8):1532-8. PubMed ID: 22642402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms.
    Labropoulos N; Waggoner T; Sammis W; Samali S; Pappas PJ
    J Vasc Surg; 2008 Aug; 48(2):407-12. PubMed ID: 18515036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome.
    Sartori M; Favaretto E; Cini M; Legnani C; Palareti G; Cosmi B
    Thromb Res; 2014 Aug; 134(2):320-5. PubMed ID: 24968959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute prognostic factors for post-thrombotic syndrome in children with limb DVT: a bi-institutional cohort study.
    Lyle CA; Gibson E; Lovejoy AE; Goldenberg NA
    Thromb Res; 2013 Jan; 131(1):37-41. PubMed ID: 23195142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biases of Villalta scale in classifying post-thrombotic syndrome in patients with pre-existing chronic venous disease.
    Ning J; Ma W; Fish J; Trihn F; Lurie F
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1025-1030. PubMed ID: 32205129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: A population-based, cross-sectional study.
    Wik HS; Jacobsen AF; Mowinckel MC; Sandset PM
    Thromb Res; 2016 Feb; 138():16-21. PubMed ID: 26826503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute phase determinant of post-thrombotic syndrome: A review of the literature.
    Khider L; Planquette B; Smadja DM; Sanchez O; Rial C; Goudot G; Messas E; Mirault T; Gendron N
    Thromb Res; 2024 Jun; 238():11-18. PubMed ID: 38643521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between deep vein thrombosis and stent patency in symptomatic iliac vein compression syndrome: Systematic review and meta-analysis.
    Rodrigues LDS; Bertanha M; El Dib R; Moura R
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):275-284. PubMed ID: 32827731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting development of post-thrombotic syndrome in patients with a first episode of deep vein thrombosis: preliminary report.
    Yamaki T; Hamahata A; Soejima K; Kono T; Nozaki M; Sakurai H
    Eur J Vasc Endovasc Surg; 2011 Jan; 41(1):126-33. PubMed ID: 21112226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between D-dimer level, venous valvular reflux and the development of post-thrombotic syndrome after deep vein thrombosis.
    Latella J; Desmarais S; Miron MJ; Roussin A; Joyal F; Kassis J; Solymoss S; Desjardins L; Ginsberg JS; Kahn SR
    J Thromb Haemost; 2010 Oct; 8(10):2169-75. PubMed ID: 20670369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.
    Chitsike RS; Rodger MA; Kovacs MJ; Betancourt MT; Wells PS; Anderson DR; Chagnon I; LE Gal G; Solymoss S; Crowther MA; Perrier A; White RH; Vickars LM; Ramsay T; Kahn SR
    J Thromb Haemost; 2012 Oct; 10(10):2039-44. PubMed ID: 22846068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of markers of inflammation in the postthrombotic syndrome: a systematic review: inflammatory biomarkers and PTS.
    Rabinovich A; Cohen JM; Kahn SR
    Thromb Res; 2015 Aug; 136(2):289-97. PubMed ID: 26139086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.